Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
NITRAZEPAM
Meda Health Sales Ireland Limited
N05CD02
NITRAZEPAM
5 Milligram
Tablets
Product subject to prescription which may not be renewed (A)
Benzodiazepine derivatives
Authorised
2009-04-24
Package leaflet: Information for the user MOGADON 5MG TABLETS Nutazepam READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Mogadon tablets are and what are they used for. 2. What you need to know before you take Mogadon tablets 3. How to take Mogadon tablets 4. Possible side effects 5. How to store Mogadon tablets 6. Contents of the pack and other information 1. WHAT MOGADON TABLETS ARE AND WHAT THEY ARE USED FOR Mogadon tablets contain the active ingredient nitrazepam, which belongs to a group of medicines called benzodiazepines. Mogadon tablets are used for severe insomnia (sleeplessness). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MOGADON TABLETS DO NOT TAKE MOGADON TABLETS: - If you are allergic ( hypersensitive) to nitrazepam, - If you are allergic to other similar drugs ( benzodiazepines) - If you are allergic to any of the other ingredients of Mogadon tablets (listed in section 6). An allergic reaction may include rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue. - If you have a condition called myasthenia gravis - If you have severe breathing difficulties - If you have sleep apnoea syndrome ( breathing problems when asleep) - If Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mogadon 5 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Mogadon tablet contains 5 mg of Nitrazepam. Excipients: also includes lactose monohydrate 301mg per tablet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Round, white tablets with “V” over “MOG5” marked on one side and with a single break-line on the other. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Insomnia Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Insomnia_ _Adults:_ _Elderly or debilitated patients:_ The elderly or patients with impaired renal and/or hepatic function will be particularly susceptible to adverse effects of Mogadon. Doses should not exceed half those normally recommended. If organic brain changes are present, the dosage of Mogadon should not exceed 5mg in these patients. _Children:_ Not recommended. _Other populations:_ In patients with chronic pulmonary insufficiency and in patients with chronic renal or hepatic disease, dosage may need to be reduced. Treatment should be as short as possible and should be started with the lowest possible dose. The maximum dose should not be exceeded. Generally the duration of treatment varies from a few days to two weeks with a maximum of four weeks; including the tapering off process. Patients who have taken benzodiazepines for a prolonged time may require a longer period during which doses are reduced. Specialist help may be appropriate. Little is known regarding the efficacy or safety of benzodiazepines in long-term use. In certain cases, extension beyond the maximum treatment Read the complete document